Clinical Trial Update: Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing clotrimazole (generic) versus Mycelex brand of clotrimazole for treating oropharyngeal candidiasis in HIV-infected patients; study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Candidiasis

Drugs mentioned

• Clotrimazole (clotrimazole)
• Mycelex (clotrimazole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Candidiasis, Oral | Phase 3 | Status: COMPLETED